Comparison of HPV testing and cervical cytology in prevention of cervical cancer

Comparison of HPV testing and cervical cytology in prevention of cervical cancer

Show other versions (1)

Introduction and purpose This article aims to compare two guidi...

Full description

Bibliographic Details
Main Authors:	Klaudia Remjasz, Katarzyna Kosz, Aleksandra Kuchnicka, Julia Kuchnicka, Jakub Aleksandrowicz, Martyna Zielińska, Natalia Zarankiewicz, Wojciech Siedlecki, Klaudia Sapuła
Format:	Article
Language:	English
Published:	Kazimierz Wielki University 2022-08-01
Series:	Journal of Education, Health and Sport
Subjects:	cervical cancer cervical screening cytology HPV primary screening HPV testing
Online Access:	https://apcz.umk.pl/JEHS/article/view/39486

Similar Items

Comparison of HPV testing and cervical cytology in prevention of cervical cancer
by: Klaudia Remjasz, et al.
Published: (2022-08-01)

High-risk HPV test in cervical cancer prevention – present and future
by: Natalia Zarankiewicz, et al.
Published: (2020-09-01)

Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA studyResearch in context
by: Arianis Tatiana Ramírez, et al.
Published: (2023-10-01)

Molecular Epidemiology of Human Papillomavirus Infection Among Chinese Women With Cervical Cytological Abnormalities
by: Eliza Lai-Yi Wong, et al.
Published: (2022-05-01)

Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies
by: Angela Pista, et al.
Published: (2019-02-01)

Cervical cancer - is there anything to worry about? Research on knowledge and awareness of cervical cancer among Poles
by: Dominika Mańdziuk, et al.
Published: (2024-05-01)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
by: Brandon Wen Bing Chua, et al.
Published: (2022-05-01)

Cost‐Effectiveness of Computer‐Assisted Cytology in a Primary hrHPV‐Based Cervical Cancer Screening Programme
by: Ellen M. G. Olthof, et al.
Published: (2024-10-01)

Diagnostic cervical excision in patients with HPV positivity, cytological abnormalities- and preoperative cervical stenosis
by: Agnieszka Denecke, et al.
Published: (2024-07-01)

Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil
by: Luiz Carlos Zeferino, et al.
Published: (2018-06-01)

Implementation of the regional program of cervical cancer screening by liquid-based cytology in the Rostov region
by: Т. A. Dimitriadi, et al.
Published: (2019-12-01)

Guidelines for cervical cancer screening in China
by: Mingzhu Li, et al.
Published: (2023-12-01)

HPV molecular detection from urine versus cervical samples: an alternative for HPV screening in indigenous populations
by: Francisco I. Torres-Rojas, et al.
Published: (2021-06-01)

Cervical cancer screening in Switzerland: time to rethink the guidelines
by: Pierre Vassilakos, et al.
Published: (2015-02-01)

From Satirical Poems and Invisible Poisons to Radical Surgery and Organized Cervical Cancer Screening—A Historical Outline of Cervical Carcinoma and Its Relation to HPV Infection
by: Leonard Jung, et al.
Published: (2024-02-01)

Do they cope or mope? A survey of GPs’ experiences with the changes in the Norwegian Cervical Cancer Screening Programme
by: Sofie Afseth, et al.
Published: (2022-07-01)

Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study)
by: Orlando Giovanna, et al.
Published: (2012-05-01)

The Effect of Age on Cervical Cancer Screening in Women Aged 20-29
by: Hasan Aykut Tuncer, et al.
Published: (2020-01-01)

Directions for Improving the Laboratory Component in Secondary Prevention of Cervical Cancer
by: O. B. Kuleshova, et al.
Published: (2024-09-01)

HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK
by: Sunyoung Choi, et al.
Published: (2023-02-01)

HPV-associated cervical cancer: Current status and prospects
by: E. A. Kravtsova, et al.
Published: (2023-07-01)

The Value of TruScreen (An Artificial Intelligence Cervical Cancer Screening System) in High-Risk HPV Positive Patients
by: Lianmei Luo, et al.
Published: (2023-10-01)

Prevalence and distribution of human papillomavirus genotypes in women with abnormal cervical cytology in Ethiopia: a systematic review and meta-analysis
by: Solomon Demis Kebede, et al.
Published: (2024-10-01)

HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)—study protocol of a randomised healthcare policy trial
by: Patrycja Glinska, et al.
Published: (2023-11-01)

HPV testing for cervical cancer screening: Should reflex cytology be performed after a positive test for HPV 16 and 18?
by: Vitor Caeiro, et al.
Published: (2023-01-01)

“Easy women get it”: pre-existing stigma associated with HPV and cervical cancer in a low-resource setting prior to implementation of an HPV screen-and-treat program
by: Rachel M. Morse, et al.
Published: (2023-12-01)

Factors associated with human papillomavirus infection – findings from a cervical cancer screening program for female employees in Beijing
by: Yang H, et al.
Published: (2019-08-01)

Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: the Morelos HPV study
by: Flores Yvonne, et al.
Published: (2002-01-01)

Improving cervical cancer screening in Mexico: results from the Morelos HPV Study
by: Flores Yvonne, et al.
Published: (2003-01-01)

Recommendations for cervical cancer screening programs in developing countries: the need for equity and technological development
by: Lazcano-Ponce Eduardo, et al.
Published: (2003-01-01)

Cervical cytology and HPV distribution in Cape Verde: A snapshot of a country taken during its first HPV nation-wide vaccination campaign
by: Rita Vieira, et al.
Published: (2024-06-01)

CERVICAL CANCER ELIMINATION PROGRAM
by: D.R. Kaidarova, et al.
Published: (2021-06-01)

Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China’s largest independent operator of pathology laboratories
by: Fengxiang Xie, et al.
Published: (2019-11-01)

Experience in the use of modern H-SIL diagnostic methods in the screening of cervical cancer on the example of the Rostov region
by: Tatiana A. Dimitriadi, et al.
Published: (2019-04-01)

Multiple myeloma and kidney disease
by: Natalia Zarankiewicz, et al.
Published: (2022-08-01)

Vitamin D toxicity – causes, symptoms and diagnosis
by: Katarzyna Kosz, et al.
Published: (2022-08-01)

Braf protein mutation and its significancy within patients with melanoma
by: Julia Kuchnicka, et al.
Published: (2022-08-01)

An emerging paradigms on cervical cancer screening methods and devices for clinical trails
by: Kumudha Raimond, et al.
Published: (2022-10-01)

Cytologic Differential Diagnostic Problems in Ulcerative Cervicitis
by: Demetrio Tamiolakis, et al.
Published: (2004-01-01)

Assessment of Cervicovaginal Smear and HPV DNA Co-Test for Cervical Cancer Screening: Implications for Diagnosis and Follow-Up Strategies
by: Neslihan Kaya Terzi, et al.
Published: (2024-03-01)